Utmd reports year 2024 and fourth quarter financial performance

Salt lake city, ut / access newswire / january 28, 2025 / with revenues 19% lower, net income 17% lower and earnings per share (eps) 13% lower than in 2023, utah medical products, inc. (nasdaq:utmd) concluded a year of contraction. utmd's stock price declined 27%, more than twice the eps decline, which allowed the company an opportunity to repurchase more than 8% of its shares in the open market.
K Ratings Summary
K Quant Ranking